FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2026/03/105497 [Registered on: 06/03/2026] Trial Registered Prospectively
Last Modified On: 05/03/2026
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda
Other (Specify) 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   Comparative Effect of Saptachakra Churna and Shatpushpa Churna in the Management of Painful Menstruation. 
Scientific Title of Study   A Comparative Clinical Trial to Evaluate the Efficacy of Saptachakra Churna and Shatpushpa Churna in the Management of Kashtartava W.S.R. to Primary Dysmenorrhea. 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Aishwarya Arun Bhavsar 
Designation  PG scholar  
Affiliation  SST Ayurved Mahavidyalaya,Sangamner  
Address  Department of streerog Avum prasutitantra,SST Ayurved Mahavidyalaya,Sangamner,Nashik Pune road,opposite to Prasad hotel,Dist Ahmadnagar

Ahmadnagar
MAHARASHTRA
422605
India 
Phone  8669040808  
Fax    
Email  bhavsaraishwarya1105@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Amit Shinde 
Designation  Professor and HOD 
Affiliation  SST Ayurved Mahavidyalaya,Sangamner  
Address  Department of streerog Avum prasutitantra,SST Ayurved Mahavidyalaya,Sangamner,Nashik Pune road,opposite to Prasad hotel,Dist Ahmadnagar

Ahmadnagar
MAHARASHTRA
422605
India 
Phone  9881303593  
Fax    
Email  amitshinde112@gmail.com   
 
Details of Contact Person
Public Query
 
Name  Dr Amit shinde 
Designation  Professor and HOD 
Affiliation  SST Ayurved Mahavidyalaya,Sangamner  
Address  Department of streerog Avum prasutitantra,SST Ayurved Mahavidyalaya,Sangamner,Nashik Pune road,opposite to Prasad hotel,Dist Ahmadnagar

Ahmadnagar
MAHARASHTRA
422605
India 
Phone  9881303593  
Fax    
Email  amitshinde112@gmail.com  
 
Source of Monetary or Material Support  
SST Ayurved Mahavidyalaya,Sangamner,Nashik Pune Road,opposite to Prasad Hotel,Dist Ahmadnagar 422605 India  
 
Primary Sponsor  
Name  Dr Aishwarya Arun Bhavsar 
Address  Department of Streerog Avum prasutitantra, SST Ayurved Mahavidyalaya Sangamner, Nashik Pune Road,opposite to Prasad Hotel, Dist.Ahmadnagar 422605 India 
Type of Sponsor  Other [Self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL   NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Aishwarya Arun Bhavsar  SST Ayurved College Sangamner Ahmadnagar   OPD division 1st floor, room number 1 ,Streerog Avum Prasutitantra OPD,SST Ayurved College Sangamner,Nashik Pune road,opposite Prasad hotel,Ahmadnagar
Ahmadnagar
MAHARASHTRA 
8669040808

bhavsaraishwarya1105@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
SST Ayurved Mahavidyalaya Sangamner   Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:N944||Primary dysmenorrhea. Ayurveda Condition: ARTAVAVAHA-SROTODUSHTIH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Comparator ArmDrugClassical(1) Medicine Name: Shatpushpa churna, Reference: Kashyap sanhita ,kalpsthana shatpushpashatavari kalpaadhayay 5,6, Route: Oral, Dosage Form: Churna/ Powder, Dose: 3(g), Frequency: bd, Bhaishajya Kal: Pragbhakta, Duration: 12 Weeks, anupAna/sahapAna: Yes(details: -koshna Jala), Additional Information: -
2Intervention ArmDrugClassical(1) Medicine Name: Saptachakra churna, Reference: Dravyagun vigyan priyavatsharma, Route: Oral, Dosage Form: Churna/ Powder, Dose: 3(g), Frequency: bd, Bhaishajya Kal: Pragbhakta, Duration: 12 Weeks, anupAna/sahapAna: Yes(details: -koshna Jala), Additional Information: -
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  49.00 Year(s)
Gender  Female 
Details  Nulliparous women in reproducive age group with Regular menstrual cycle and Having minimum any 3 signs and symptoms of dysmenorrhea for more than 3 consecutive cycles i.e
i)Painful period
ii)Pain in the lower abdomen.
iii)Lower backpain
iv)Fatigue
V)Nausea. 
 
ExclusionCriteria 
Details  1. K/C/O Any serious systemic disease.
2. K/C/O congenital abnormalities that cause Kashtartava in relation to primary dysmenorrhea.
3.K/C/O of dysmenorrhea with any uterine pathological condition
K/C/O Adenomyosis, endometrial polyp, uterine fibroid, and endometriosis
4. K/C/O Inflammatory disorders of the pelvis.
5. Those undergoing hormone therapy.
6. K/C/O STD’s (sexually transmitted disorders). 
 
Method of Generating Random Sequence   Coin toss, Lottery, toss of dice, shuffling cards etc 
Method of Concealment   Alternation 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
To Decrease the duration of
menstrual pain, Intensity of pain in lower abdomen,Intensity of backpain,fatigue,and nausea 
Total duration of treatment -12 weeks
Assessment on 1st day, day 5 of 1st,2nd,3rd menstrual cycle 
 
Secondary Outcome  
Outcome  TimePoints 
NIL  NIL 
 
Target Sample Size   Total Sample Size="80"
Sample Size from India="80" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   22/03/2026 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   TITLE -“A Comparative Clinical Trial to Evaluate the Efficacy of Saptachakra Churna and Shatpushpa Churna in the Management of KashtartavaW.S.R. to Primary Dysmenorrhea.”



INTRODUCTION -Several studies in India found that the prevalence of dysmenorrhea was 77%.It is still unknown what causes uterine pain in primary dysmenorrhea.
However, a number of risk factors have been found, including smoking, stress/depression, nulliparity, early menarche, young age, and positive family history.
In ayurveda Saptchakra (Salacia chinensis) Churna and Shatapushpa (Anethum graveolens) Churna are indicated in Kashtartavahara. Both these drugs are proven earlier but their comparative efficacy is not yet explored Hence study has been planned entitled ‘Comparative Clinical trial to evaluate the effect of Saptchakra 
Churna and Shatpushpa Churna in the management of Kashtartava W.S.R. to Primary Dysmenorrhea.’


SAMPLE SIZE -Total sample size for study will be 80 participants divided equally between 2 groups.


NULl HYPOTHESIS (H0)-There is no statistically significant difference in the efficacy of Saptachakra Churna and Shatpushpa Churna in the management of Kashtartava W.S.R to Primary Dysmenorrhoea. 


Alternate Hypothesis (H1)-There is statistically significant difference in the efficacy of SaptchakraChurna and Shatpushpa Churna in the management of Kashtartava W.S.R. to Primary Dysmenorrhea 
 
Close